 |
|
|
|
 |
|
|
| Article 1 to 10 out of 14 concerning Thermo Fisher Scientific, Inc.
|
-
Closing of the successful sale of BRAHMS to Thermo Fisher Scientific
(06 Oct 2009)
The sale of BRAHMS to Thermo Fisher Scientific was closed. HBM BioVentures received net sales proceeds of CHF 128 million at the same time. The equity investment in BRAHMS was multiplied by a factor of 21.6 times.
-
Successful sale of BRAHMS in an all cash transaction to Thermo Fisher
(04 Sep 2009)
Scientific leads to NAV increase of CHF 8.88, or 15.5%
Thermo Fisher Scientific Inc. and BRAHMS Holding GmbH announced the signing of a definitive Share Purchase Agreement. Under the terms of the agreement Thermo Fisher Scientific will acquire all issued shares of BRAHMS for a gross purchase price of ...
-
Thermo Fisher Scientific Wins Microsoft Pharmaceutical and Life Sciences Innovation Award in Informatics
(02 Jul 2009)
Thermo Fisher Scientific Inc. announced that it has been named the winner of the Microsoft Corporation 2009 Pharmaceutical and Life Sciences Innovation Award in the Discovery and Product Innovation category, for the second consecutive year. The ...
-
Fisher HealthCare becomes exclusive distributor of Flow Cytometry Reagents for Dako Reagent Partnership Division
(06 May 2009)
Dako, Reagent Partnership Division, has entered into a five-year agreement with Fisher HealthCare, a division of Thermo Fisher Scientific. Under this agreement, Fisher Healthcare has been granted the exclusive right to distribute Flow Cytometry ...
-
Symyx announce partnership with Thermo Fisher Scientific
(25 Mar 2009)
Symyx Technologies, Inc. has announced the signing of a partnership with Thermo Fisher Scientific, Inc. The partnership will focus on delivering to scientists improved workflows meeting their experiment documentation, decision support, and ...
-
Thermo Fisher Scientific Acquires Affinity BioReagents
(21 Jul 2008)
Broad Range of Antibody Products Expands Thermo Fisher's Protein-Research Offering
Thermo Fisher Scientific Inc. announced that it has acquired Affinity BioReagents, provider of antibodies, peptides, proteins and other reagents for life science research, based in Golden, Colorado."Affinity BioReagents is an ideal complement to our ...
-
Analytik Jena and Fisher Scientific conclude a marketing and sales agreement
(15 Jul 2008)
Analytik Jena and Fisher Scientific have entered into a marketing and sales agreement for the German Market. The broad range of reagenetic equipment and instruments of the Jena Group will appear in future in the Fisher Scientific Sales Catalogue and ...
-
Thermo Fisher Scientific acquires Open Biosystems
(02 Jul 2008)
Creating unmatched RNAi platform
Thermo Fisher Scientific Inc. announced that it has acquired Open Biosystems, Inc., a provider of RNA interference (RNAi), gene expression and protein detection products for life science research and drug discovery and development. The acquisition ...
-
Thermo Fisher Scientific and George Mason University Partner in Protein Biomarker Research Project
(30 May 2008)
Collaboration Aims to Accelerate Verification and Validation of Protein Biomarkers for Earlier Disease Diagnosis and Therapeutic Efficacy
Thermo Fisher Scientific Inc. announced an alliance between its Biomarker Research Initiatives in Mass Spectrometry (BRIMS) Center and George Mason University's Center for Applied Proteomics and Molecular Medicine (CAPMM) to accelerate biomarker ...
-
Thermo Fisher Scientific Announces Collaborative Partnership with Vascular Proteomics Group at King's College London
(01 Feb 2008)
Thermo Fisher Scientific Inc. announced a collaborative partnership with the newly opened Vascular Proteomics Group at the James Black Center, King's College London, headed by Dr. Manuel Mayr. Started in June 2007, the facility is equipped with the ...
Additional information
Thermo Fisher Scientific, Inc.
Waltham, Mass, USA
Products
|
|
|
|
|
|
Top
